手术中低血压的前瞻性 vs 反应性治疗:PRETREAT 随机临床试验
该随机临床试验在荷兰两家三级医院纳入接受择期非心脏手术的成人,比较基于术中低血压风险分层的主动性血压管理与常规管理对术后6个月功能残疾的影响。试验因无效提前终止,共纳入3247例(计划5000例)。6个月时WHODAS 2.0平均分主动组17.7 vs 常规组18.2,平均差-0.5(95%可信区间-1.9至0.9),23项次要结局均无显著差异。
要点
- 基于低血压风险分层的术中平均动脉压目标管理未改善术后6个月功能残疾。
- 主动组与常规组6个月WHODAS 2.0平均分差异为-0.5(95%可信区间-1.9至0.9)。
- 23项次要结局(含生活质量、并发症和6个月内死亡)均无显著差异。
核心结论
- 与常规术中血压管理相比,基于低血压风险分层的平均动脉压目标管理未改善术后6个月功能残疾。
研究设计与样本
- 随机临床试验,在荷兰2家三级医院纳入接受择期非心脏手术的成人,入组时间2021年6月17日至2024年2月7日,末次随访日期2024年10月24日。
- 患者按1:1随机分配至主动性血压管理组或常规管理组;主动性管理依据术中低血压风险设定平均动脉压目标(低风险≥70 mm Hg,中风险≥80 mm Hg,高风险≥90 mm Hg),常规管理由麻醉医师酌情决定,一般以避免平均动脉压低于65 mm Hg为目标而无更高预设目标。
- 计划纳入5000例,因无效提前终止,实际纳入3247例(中位年龄59岁[IQR 44-69];女性1738例[53.5%]);低风险677例(21%),中风险1814例(56%),高风险756例(23%)。
主要发现
- 基线WHODAS 2.0中位评分主动组为12.5(IQR 4.2-29.2),常规组为14.6(IQR 4.2-29.2)。
- 6个月时WHODAS 2.0平均(SD)评分主动组为17.7(20.1),常规组为18.2(20.5),平均差-0.5(95%可信区间-1.9至0.9)。
- 23项次要结局均无显著差异,包括生活质量、并发症和6个月内死亡。
关键数值与推荐
- 主要结局为术后6个月功能残疾,采用12项世界卫生组织残疾评定量表2.0(WHODAS 2.0;评分范围0-100,分数越高残疾越重),预设最小临床重要差异为5分。
- 主动性管理组平均动脉压目标:低风险≥70 mm Hg,中风险≥80 mm Hg,高风险≥90 mm Hg。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验因无效提前终止,实际纳入3247例,低于计划的5000例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Intraoperative hypotension is associated with adverse postoperative outcomes, but whether a proactive strategy to prevent intraoperative hypotension improves outcomes is uncertain. OBJECTIVE: To determine whether intraoperative blood pressure management stratified by risk of hypotension reduces postoperative functional disability compared with usual care in adults undergoing noncardiac surgery. DESIGN, SETTING, AND PARTICIPANTS: In this randomized clinical trial, adults undergoing elective noncardiac surgery at 2 tertiary hospitals in the Netherlands were enrolled from June 17, 2021, to February 7, 2024. The date of last follow-up was October 24, 2024. INTERVENTION: Patients were randomized 1:1 to proactive blood pressure management with mean arterial pressure targets based on risk of intraoperative hypotension (low risk, ≥70 mm Hg; intermediate risk, ≥80; high risk, ≥90) or usual management at their anesthesiologist's discretion, generally aiming to avoid a mean arterial pressure of less than 65 mm Hg without higher predefined targets. MAIN OUTCOMES AND MEASURES: The primary outcome was functional disability at 6 months, assessed with the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0; scale range, 0-100; higher scores indicate more disability). A minimally clinically important difference of 5 points was prespecified. There were 23 secondary outcomes, including quality of life, complications, and mortality within 6 months. RESULTS: The trial was stopped early for futility after 3247 of 5000 planned patients (median age, 59 years [IQR, 44-69]; 1738 female [53.5%]) were enrolled. A total of 677 patients (21%) were low risk; 1814 (56%), intermediate risk, and 756 (23%), high risk. Baseline median WHODAS scores were 12.5 [IQR, 4.2-29.2] in proactive group and 14.6 [IQR, 4.2-29.2] in standard group). At 6 months, mean (SD) WHODAS scores were 17.7 (20.1) in the proactive group and 18.2 (20.5) in the standard group (mean difference, -0.5; 95% credible interval, -1.9 to 0.9). There were no significant differences in any of the 23 secondary outcomes. CONCLUSIONS AND RELEVANCE: Intraoperative blood pressure management with mean arterial pressure goals stratified by risk of hypotension did not improve functional disability at 6 months postoperatively compared with standard intraoperative blood pressure management. TRIAL REGISTRATION: Overview of Medical Research in the Netherlands (CCMO): NL-OMON55117.
引用
- Kant M, van Klei WA, Hollmann MW, et al. Proactive vs Reactive Treatment of Hypotension During Surgery: The PRETREAT Randomized Clinical Trial. JAMA. 2025. PMID: 41076587. doi:10.1001/jama.2025.18007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。